- Home
- CLLS vs TBI Comparison
CLLS vs TBI Comparison
Compare CLLS & TBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | TBI |
|---|---|---|
| Founded | 1999 | 1985 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 299.0M | 139.9M |
| IPO Year | 2007 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CLLS | TBI |
|---|---|---|
| Price | $4.69 | $4.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $8.00 | $6.00 |
| AVG Volume (30 Days) | 133.9K | ★ 205.6K |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $82,551,000.00 | ★ $1,583,772,000.00 |
| Revenue This Year | $32.58 | $3.80 |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $3.45 |
| 52 Week High | $5.48 | $8.60 |
Technical Indicators
Market Signals| Indicator | CLLS | TBI |
|---|---|---|
| Relative Strength Index (RSI) | 54.08 | 41.67 |
| Support Level | $4.47 | $4.61 |
| Resistance Level | $5.45 | $4.98 |
| Average True Range (ATR) | 0.30 | 0.19 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 50.65 | 14.06 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.